
La Roche-Posay

Sunscreens
This formula needs extra consideration during pregnancy. Review the flagged ingredients with your healthcare professional.
33 of 33 ingredients rated
MamaSkin rates the recorded formula for La Roche-Posay Anthelios UVAIR SPF50+ as Medium risk (55/100). Discuss the flagged ingredients with a qualified healthcare professional before using this formula during pregnancy.
The recorded formula includes 3 ingredient entries with risk flags: Butyl Methoxydibenzoylmethane (Medium risk), Triethanolamine (Low risk), Parfum (Low risk). These are ingredient-level flags; they do not replace the stored product assessment or account for every formulation detail.
33 of 33 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
How we assess productsThe recorded formula, with evidence behind each rating. Unmatched ingredients are marked Not assessed in grey.
Butyl methoxydibenzoylmethane (avobenzone) is a UVA filter used in sunscreens. Reviews note potential endocrine-related signals for several organic UV filters, but data are often not sufficient to establish endocrine disruption, and systemic exposure depends on formulation and use pattern. Pregnancy-specific human outcome data for topical exposure are limited; the key signal is uncertainty around systemic/endocrine effects rather than a well-defined pregnancy outcome dataset.
Sources: TGA: Safety review of seven active sunscreen ingredients https://www.tga.gov.au/resources/publication/corporate-reports/safety-review-seven-active-sunscreen-ingredients
Triethanolamine (TEA) is an alkanolamine used as a pH adjuster and surfactant in cosmetics. The main practical concerns are skin/eye irritation at higher concentrations and the potential formation of nitrosamines if formulated with nitrosating agents (a formulation/impurity-control issue). It is not a typical pregnancy-specific concern at cosmetic use levels; overall risk is primarily local irritation/sensitisation in susceptible users.
Sources: CIR: Triethanolamine ingredient safety information https://www.cir-safety.org/ingredient/triethanolamine
Umbrella term for an undisclosed fragrance blend. It’s not usually a pregnancy-specific concern at normal cosmetic use levels, but the exact components and concentrations aren’t fully disclosed on the label, so we score it more conservatively. If you prefer maximum transparency (or you’re sensitive to fragrance compounds), choose fragrance-free/unscented products.
Sources: SCCS: Fragrance allergens in cosmetic products https://health.ec.europa.eu/latest-updates/sccs-new-opinion-fragrance-allergens-cosmetic-products-2012-07-31_en
Water (Aqua) is the standard purified water used as a cosmetic solvent. It has no pregnancy-specific risk in normal topical use.
Sources: https://pubchem.ncbi.nlm.nih.gov/compound/Water, https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database/cosing-glossary-ingredients_en
Volatile solvent used to improve texture, drying time, and penetration in some formulas. Reviewed cosmetic safety sources support current cosmetic use, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed; the main practical issue is dryness, stinging, or barrier disruption in some users.
Sources: CIR: Safety Assessment of SD Alcohol 40, Benzyl Alcohol, and Denatured Alcohol in Cosmetic Products; EU CosIng / cosmetics regulatory inventory
An ester of a dicarboxylic acid used as an emollient, solvent or texture agent. Cosmetic safety reviewers concluded that the assessed alkyl dicarboxylic acid esters are safe in current practices of use and concentration. No pregnancy-specific concern was identified for normal topical exposure.
Sources: CIR: Safety Assessment of Alkyl Dicarboxylic Acid Esters as Used in Cosmetics https://cir-reports.cir-safety.org/view-attachment/?id=d8d3785f-8e74-ec11-8943-0022482f06a6
Light emollient carbonate ester used to improve spreadability and reduce greasiness. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Dialkyl Carbonates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Modern broad-spectrum UV filter (often known as Tinosorb S). It has a high molecular weight and is formulated to remain mainly in the outer skin layers, with very low systemic absorption at cosmetic use levels. EU regulatory assessments and independent risk–benefit reviews have evaluated this filter as safe up to 10% in sunscreens, with no specific reproductive or developmental toxicity signals identified in animals or humans at permitted concentrations.
Sources: European Union Cosmetic Products Regulation (Annex VI): Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine listed as an approved UV filter up to 10% in cosmetic products. Mikkelsen SH et al. “Survey and health assessment of UV filters” – Danish EPA, 2015: includes Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine and notes low systemic exposure at approved use levels.
UV filter used in sunscreens and day products to help absorb UVB radiation. Reviewed cosmetic safety and regulatory sources support current cosmetic use within applicable concentration limits, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed.
Sources: EU CosIng Annex VI / UV filters; EU scientific opinion on Ethylhexyl Triazone (Uvinul T 150)
This emollient ester improves slip and skin feel. Cosmetic Ingredient Review assessments support use in current cosmetic concentrations when formulated to be non-irritating; topical use is not identified as a pregnancy- or breastfeeding-specific concern. Some alkyl esters can increase penetration of other formula ingredients.
Sources: CIR: Safety Assessment of Alkyl Esters as Used in Cosmetics https://cir-safety.org/supplementaldoc/safety-assessment-alkyl-esters-used-cosmetics
Glycerin is a widely used humectant that supports hydration and the skin barrier, with a long safety record and no known pregnancy or breastfeeding concerns in topical cosmetic use.
Sources: CIR; EU/UK Cosmetics Regulation
Mineral absorbent and texture aid used to mattify and improve slip. Reviewed cosmetic safety sources support normal topical cosmetic use; this assessment does not cover deliberate inhalation of loose powder.
Sources: CIR: Safety Assessment of Silica and Silicates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
A propylene-glycol fatty-acid ester used as an emollient and dispersing agent. Cosmetic safety reviewers concluded that the assessed propylene glycol esters are safe in current practices when formulated to be non-irritating. No pregnancy-specific concern was identified for normal topical exposure.
Sources: CIR: Safety Assessment of Propylene Glycol Esters as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-propylene-glycol-esters-used-cosmetics
An alkyl phosphate surfactant and emulsifier used to stabilise creams, sunscreens and makeup. Cosmetic safety reviewers concluded that the assessed alkyl phosphates, including potassium cetyl phosphate, are safe in current practices of use and concentration when formulated to be non-irritating. Dermal penetration is expected to be limited, and no pregnancy-specific concern is identified for normal topical cosmetic exposure.
Sources: CIR: Safety Assessment of Alkyl Phosphates https://www.cir-safety.org/sites/default/files/alkyl%20phosphates_0.pdf
Carnauba wax, a plant-derived wax used to structure and thicken cosmetics. Cosmetic safety assessments and long-standing regulated use support normal topical exposure. No pregnancy-specific concern was identified; plant sensitivity remains possible.
Sources: CIR plant wax and Copernicia cerifera-derived ingredient assessments; FDA: Color Additives Permitted for Use in Cosmetics; European Commission CosIng ingredient inventory.
Modern UVA filter (often called Uvinul A+ or DHHB). Regulatory assessments have repeatedly evaluated this filter as safe in cosmetic products at concentrations up to 10%. The most recent SCCS advice focuses on controlling a manufacturing impurity (DnHexP) rather than on new toxicity of DHHB itself. Human biomonitoring data indicate low systemic exposure from normal sunscreen use, and current reviews do not identify specific reproductive or developmental toxicity signals at approved concentrations.
Sources: SCCP opinion referenced in Directive 2008/123/EC: concludes that Diethylamino Hydroxybenzoyl Hexyl Benzoate used at a maximum of 10% in cosmetic (including sunscreen) products does not pose a risk to the consumer. Regulatory summaries (e.g. CosLaw and CIRS Group updates, 2025) reviewing the SCCS DHHB opinion and reiterating that DHHB remains permitted up to 10% in EU cosmetics when impurity limits are respected.
Polymer thickener and stabiliser used in creams and sunscreens. Low systemic exposure expected.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Preservative used to help protect formulas from microbial growth. Reviewed cosmetic safety sources support present cosmetic use; no pregnancy- or breastfeeding-specific topical concern was identified in the material reviewed, although some users may still notice local irritation or sensitivity.
Sources: CIR: Safety Assessment of Chlorphenesin as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
pH adjuster used in small amounts to maintain product stability. Not associated with pregnancy-specific concerns.
Sources: Scientific Committee on Consumer Safety (EU); European cosmetics regulatory framework
Emulsifier and emollient used to stabilise creams and lotions. Not associated with pregnancy-specific concerns at cosmetic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Hydroxyacetophenone is used as an antioxidant and preservative-support ingredient; it is generally considered low concern in topical cosmetic use with no known pregnancy or breastfeeding risks at typical concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
This naturally occurring fatty acid is used for emolliency, cleansing support or texture. The Cosmetic Ingredient Review concluded that assessed fatty acids are safe in current cosmetic use when formulated to be non-irritating and non-sensitizing; some can increase penetration of other formula ingredients.
Sources: CIR: Safety Assessment of Fatty Acids and Fatty Acid Salts as Used in Cosmetics https://cir-safety.org/supplementaldoc/safety-assessment-fatty-acids-fatty-acid-salts-used-cosmetic
Niacinamide (vitamin B3) is widely used for barrier support and tone/texture benefits, and is generally considered safe in pregnancy and breastfeeding when used topically at cosmetic concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Fatty acid used as an emollient, cleansing-support and texture ingredient. It is not associated with pregnancy- or breastfeeding-specific concerns in normal topical cosmetic use.
Sources: CIR: Safety Assessment of Fatty Acids and Fatty Acid Salts as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Emulsifier used to stabilize creams and lotions. Reviewed cosmetic safety sources support use of PEG stearates in cosmetics, with no pregnancy- or breastfeeding-specific concern identified for normal topical use.
Sources: CIR: Safety Assessment of PEG Stearates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Humectant and preservative booster. Considered safe for cosmetic use with low systemic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
An insoluble mineral or elemental particle used for optical effects, absorbency or cosmetic texture. Meaningful systemic exposure through intact skin is expected to be low. No pregnancy- or reproductive-toxicity signal was identified for normal topical cosmetic use. Particle size, source purity, metal impurities and inhalation of airborne powder remain formulation-specific considerations, and local contact allergy is possible with gold.
Sources: European Commission CosIng ingredient inventory; SCCS guidance on the safety assessment of nanomaterials in cosmetics https://health.ec.europa.eu/scientific-committees/scientific-committee-consumer-safety-sccs_en; published cosmetic and dermatology literature for gold, diamond powder and perlite.
A surface-modified silica used to thicken oils and improve texture. Cosmetic safety reviewers concluded that silica silylate is safe in current practices when the final product is not irritating or sensitising to the respiratory tract. Avoid deliberately inhaling loose or airborne powder.
Sources: CIR: Safety Assessment of Silica Silylate, IJT 32(Suppl. 1), 2013; December 2025 Quick Reference Table https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf
Sodium hyaluronate (hyaluronic acid salt) is used for hydration and cushioning, with very low systemic absorption from topical use and no known pregnancy or breastfeeding concerns at cosmetic concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Stearic acid is a fatty acid used to stabilise emulsions and improve texture; it is considered low concern in topical cosmetics with no known pregnancy or breastfeeding risks at typical concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Vitamin E antioxidant used to protect oils and support the skin barrier. Not associated with pregnancy-specific concerns at cosmetic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Chelating ingredient used to improve formula stability by binding trace metals. Reviewed cosmetic ingredient references do not identify a pregnancy- or breastfeeding-specific concern for normal topical use.
Sources: CIR cosmetic ingredient safety references for chelating agents; EU CosIng / cosmetics regulatory inventory
Natural polysaccharide thickener used for stability and texture. Not associated with pregnancy-specific concerns.
Sources: European cosmetics regulatory framework
Water, Alcohol Denat., Diisopropyl Sebacate, Dicaprylyl Carbonate, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Ethylhexyl Triazone, Butyl Methoxydibenzoylmethane, Isopropyl Myristate, Glycerin, Silica, Propylene Glycol Dicaprylate/Dicaprate, Potassium Cetyl Phosphate, Copernicia Cerifera Cera, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Chlorphenesin, Citric Acid, Glyceryl Stearate, Hydroxyacetophenone, Myristic Acid, Niacinamide, Palmitic Acid, PEG-100 Stearate, Pentylene Glycol, Perlite, Silica Silylate, Sodium Hyaluronate, Stearic Acid, Tocopherol, Triethanolamine, Trisodium Ethylenediamine Disuccinate, Xanthan Gum, Parfum
Ingredient ratings refreshed 1 October 2026. Formulas vary by market and can change. Always compare with your packaging.
The recorded formula includes 3 ingredient entries with risk flags: Butyl Methoxydibenzoylmethane (Medium risk), Triethanolamine (Low risk), Parfum (Low risk). These are ingredient-level flags; they do not replace the stored product assessment or account for every formulation detail. The product score is a stored assessment, not a clinical safety guarantee.
No. The score and risk band describe MamaSkin's pregnancy-focused ingredient screening of this recorded formula. They do not measure SPF, UVA protection, water resistance or whether you have applied enough sunscreen. Use the protection and application instructions on your exact packaging, and review the ingredient flags separately.
33 of 33 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
Only if the ingredient list on your packaging matches the recorded formula shown here. Formulas can differ by market and change over time. Compare the full list, not just the product name; report a mismatch if it differs.
No. This page presents a pregnancy-focused product assessment. Do not infer a breastfeeding conclusion from its score or label; breastfeeding requires a separate assessment of the formula and how it is used.